MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis.
A colorimetric cell proliferation assay using soluble tetrazolium salt [(CellTiter 96(R) Aqueous One Solution) cell proliferation reagent, containing the (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) and an electron coupling reagent phenazine ethosulfate], was optimized and qualified for quantitative determination of IL-15 dependent CTLL-2 cell proliferation activity. An in-house recombinant Human (rHu)IL-15 reference lot was standardized (IU/mg) against an international reference standard. Specificity of the assay for IL-15 was documented by illustrating the ability of neutralizing anti-IL-15 antibodies to block the product specific CTLL-2 cell proliferation and the lack of blocking effect with anti-IL-2 antibodies. Under the defined assay conditions, the linear dose-response concentration range was between 0.04 and 0.17ng/ml of the rHuIL-15 produced in-house and 0.5-3.0IU/ml for the international standard. Statistical analysis of the data was performed with the use of scripts written in the R Statistical Language and Environment utilizing a four-parameter logistic regression fit analysis procedure. The overall variation in the ED(50) values for the in-house reference standard from 55 independent estimates performed over the period of 1year was 12.3% of the average. Excellent intra-plate and within-day/inter-plate consistency was observed for all four parameter estimates in the model. Different preparations of rHuIL-15 showed excellent intra-plate consistency in the parameter estimates corresponding to the lower and upper asymptotes as well as to the 'slope' factor at the mid-point. The ED(50) values showed statistically significant differences for different lots and for control versus stressed samples. Three R-scripts improve data analysis capabilities allowing one to describe assay variations, to draw inferences between data sets from formal statistical tests, and to set up improved assay acceptance criteria based on comparability and consistency in the four parameters of the model. The assay is precise, accurate and robust and can be fully validated. Applications of the assay were established including process development support, release of the rHuIL-15 product for pre-clinical and clinical studies, and for monitoring storage stability.
Soman
Gopalan
G
Department of Process Analytics, Biopharmaceutical Development Program, SAIC-Frederick, Inc., United States. somang@mail.nih.gov
Yang
Xiaoyi
X
Jiang
Hengguang
H
Giardina
Steve
S
Vyas
Vinay
V
Mitra
George
G
Yovandich
Jason
J
Creekmore
Stephen P
SP
Waldmann
Thomas A
TA
Quiñones
Octavio
O
Alvord
W Gregory
WG
D000906:Antibodies / Q000494:pharmacology; D001681:Biological Assay / Q000592:standards; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D003124:Colorimetry / Q000379:methods* / Q000592:standards; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D019409:Interleukin-15 / Q000494:pharmacology* / Q000592:standards; D007376:Interleukin-2 / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology / Q000592:standards; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013778:Tetrazolium Salts / Q000737:chemistry*; D013844:Thiazoles / Q000737:chemistry*
D000906:Antibodies; C508594:IL2 protein, human; D019409:Interleukin-15; D007376:Interleukin-2; D011994:Recombinant Proteins; D013778:Tetrazolium Salts; D013844:Thiazoles; C070380:3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium